{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nonalcoholic+Fatty+Liver+Disease+%28NAFLD%29&page=17", "query": { "condition": "Nonalcoholic Fatty Liver Disease (NAFLD)", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 550, "total_pages": 55, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nonalcoholic+Fatty+Liver+Disease+%28NAFLD%29&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nonalcoholic+Fatty+Liver+Disease+%28NAFLD%29&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T16:47:13.444Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04801849", "title": "Vitamin E Dosing Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonalcoholic Fatty Liver Disease", "Nonalcoholic Steatohepatitis" ], "interventions": [ { "name": "Vitamin E", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2022-08-05", "completion_date": "2025-06-30", "has_results": true, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 9, "location_summary": "La Jolla, California • Los Angeles, California • San Francisco, California + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04801849" }, { "nct_id": "NCT03656068", "title": "An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-alcoholic Steatohepatitis", "Fatty Liver", "Fibrosis, Liver", "Compensated Cirrhosis" ], "interventions": [ { "name": "Nitazoxanide 500mg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pinnacle Clinical Research, PLLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 21, "start_date": "2018-12-04", "completion_date": "2020-11-25", "has_results": true, "last_update_posted_date": "2022-06-30", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03656068" }, { "nct_id": "NCT05623189", "title": "HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonalcoholic Steatohepatitis (NASH)", "Type 2 Diabetes" ], "interventions": [ { "name": "HTD1801", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "HighTide Therapeutics (Hong Kong) Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 218, "start_date": "2022-12-27", "completion_date": "2025-03-31", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 43, "location_summary": "Chandler, Arizona • Peoria, Arizona • Tucson, Arizona + 36 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05623189" }, { "nct_id": "NCT04702490", "title": "Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NASH", "NASH - Nonalcoholic Steatohepatitis", "Type 2 Diabetes", "Diabetes Type 2", "Diabetes", "Fatty Liver", "Fatty Liver, Nonalcoholic", "NAFLD" ], "interventions": [ { "name": "MET409 Active", "type": "DRUG" }, { "name": "MET409 Placebo", "type": "DRUG" }, { "name": "Empagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Metacrine, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 120, "start_date": "2020-12-15", "completion_date": "2022-06", "has_results": false, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 2, "location_summary": "Fort Myers, Florida • San Antonio, Texas", "locations": [ { "city": "Fort Myers", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04702490" }, { "nct_id": "NCT05117489", "title": "A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nonalcoholic Steatohepatitis (NASH)" ], "interventions": [ { "name": "Miricorilant 150 mg", "type": "DRUG" }, { "name": "Miricorilant 100 mg", "type": "DRUG" }, { "name": "Miricorilant 50 mg", "type": "DRUG" }, { "name": "Miricorilant 10 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corcept Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 70, "start_date": "2021-11-23", "completion_date": "2024-01-29", "has_results": false, "last_update_posted_date": "2024-08-19", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 9, "location_summary": "Chandler, Arizona • Tucson, Arizona • Panorama City, California + 6 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Panorama City", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05117489" }, { "nct_id": "NCT04480710", "title": "A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NASH - Nonalcoholic Steatohepatitis", "Fibrosis, Liver", "NAFLD - Nonalcoholic Fatty Liver Disease" ], "interventions": [ { "name": "CRV431 75mg", "type": "DRUG" }, { "name": "Placebo (1 softgel)", "type": "DRUG" }, { "name": "CRV431 225mg", "type": "DRUG" }, { "name": "Placebo (3 softgels)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hepion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 47, "start_date": "2020-06-23", "completion_date": "2021-10-30", "has_results": true, "last_update_posted_date": "2022-07-15", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 9, "location_summary": "Orange, California • Poway, California • Miami, Florida + 5 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Port Orange", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04480710" }, { "nct_id": "NCT04929483", "title": "Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NASH - Nonalcoholic Steatohepatitis" ], "interventions": [ { "name": "BIO89-100", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "89bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 222, "start_date": "2021-06-04", "completion_date": "2024-10-08", "has_results": true, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 88, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Guntersville, Alabama + 68 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Madison", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04929483" }, { "nct_id": "NCT04073368", "title": "Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "NAFLD" ], "interventions": [ { "name": "AXA1957", "type": "DIETARY_SUPPLEMENT" }, { "name": "AXA1125", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Axcella Health, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 112, "start_date": "2018-12-03", "completion_date": "2020-09-03", "has_results": true, "last_update_posted_date": "2021-07-06", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 18, "location_summary": "Chandler, Arizona • Tucson, Arizona • Huntington Park, California + 14 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Montclair", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04073368" }, { "nct_id": "NCT02267148", "title": "Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Non-alcoholic Fatty Liver Disease" ], "interventions": [], "intervention_types": [], "sponsor": "UNC Nutrition Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 53, "start_date": "2014-10", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-01-16", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 1, "location_summary": "Kannapolis, North Carolina", "locations": [ { "city": "Kannapolis", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02267148" }, { "nct_id": "NCT05199948", "title": "Weight, Energy, Lipids, and the Liver (WELL) Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nonalcoholic Fatty Liver" ], "interventions": [ { "name": "Soybean Oil Foods", "type": "OTHER" }, { "name": "Palm Oil Foods", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "22 Years to 80 Years" }, "enrollment_count": 74, "start_date": "2022-05-02", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-04-21", "last_synced_at": "2026-10-15T16:47:13.444Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05199948" } ] }